These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 29594894

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice.
    Shagdarsuren E, Bidzhekov K, Mause SF, Simsekyilmaz S, Polakowski T, Hawlisch H, Gessner JE, Zernecke A, Weber C.
    Circulation; 2010 Sep 07; 122(10):1026-36. PubMed ID: 20733098
    [Abstract] [Full Text] [Related]

  • 23. C5L2 is required for C5a-triggered receptor internalization and ERK signaling.
    Hsu WC, Yang FC, Lin CH, Hsieh SL, Chen NJ.
    Cell Signal; 2014 Jul 07; 26(7):1409-19. PubMed ID: 24631530
    [Abstract] [Full Text] [Related]

  • 24. C5a and bradykinin receptor cross-talk regulates innate and adaptive immunity in Trypanosoma cruzi infection.
    Schmitz V, Almeida LN, Svensjö E, Monteiro AC, Köhl J, Scharfstein J.
    J Immunol; 2014 Oct 01; 193(7):3613-23. PubMed ID: 25187655
    [Abstract] [Full Text] [Related]

  • 25. Complement C5a receptors C5L2 and C5aR in renal fibrosis.
    Martin IV, Bohner A, Boor P, Shagdarsuren E, Raffetseder U, Lammert F, Floege J, Ostendorf T, Weber SN.
    Am J Physiol Renal Physiol; 2018 Jan 01; 314(1):F35-F46. PubMed ID: 28903945
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Dendritic cell function in allostimulation is modulated by C5aR signaling.
    Peng Q, Li K, Wang N, Li Q, Asgari E, Lu B, Woodruff TM, Sacks SH, Zhou W.
    J Immunol; 2009 Nov 15; 183(10):6058-68. PubMed ID: 19864610
    [Abstract] [Full Text] [Related]

  • 32. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
    Li L, Chen L, Zang J, Tang X, Liu Y, Zhang J, Bai L, Yin Q, Lu Y, Cheng J, Fu P, Liu F.
    Metabolism; 2015 May 15; 64(5):597-610. PubMed ID: 25682062
    [Abstract] [Full Text] [Related]

  • 33. Complement activation product C5a is a selective suppressor of TLR4-induced, but not TLR3-induced, production of IL-27(p28) from macrophages.
    Bosmann M, Haggadone MD, Hemmila MR, Zetoune FS, Sarma JV, Ward PA.
    J Immunol; 2012 May 15; 188(10):5086-93. PubMed ID: 22491257
    [Abstract] [Full Text] [Related]

  • 34. Labile Heme Aggravates Renal Inflammation and Complement Activation After Ischemia Reperfusion Injury.
    Wang L, Vijayan V, Jang MS, Thorenz A, Greite R, Rong S, Chen R, Shushakova N, Tudorache I, Derlin K, Pradhan P, Madyaningrana K, Madrahimov N, Bräsen JH, Lichtinghagen R, van Kooten C, Huber-Lang M, Haller H, Immenschuh S, Gueler F.
    Front Immunol; 2019 May 15; 10():2975. PubMed ID: 31921212
    [Abstract] [Full Text] [Related]

  • 35. Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model.
    Atkinson SM, Nansen A, Usher PA, Sondergaard BC, Mackay CR, Friedrichsen B, Chang CC, Tang R, Skov S, Haase C, Hornum L.
    Autoimmunity; 2015 May 15; 48(7):460-70. PubMed ID: 25915570
    [Abstract] [Full Text] [Related]

  • 36. C5aR deficiency attenuates the breast cancer development via the p38/p21 axis.
    Chen J, Sun ZH, Chen LY, Xu F, Zhao YP, Li GQ, Tang M, Li Y, Zheng QY, Wang SF, Yang XH, Wu YZ, Xu GL.
    Aging (Albany NY); 2020 Jul 15; 12(14):14285-14299. PubMed ID: 32669478
    [Abstract] [Full Text] [Related]

  • 37. C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid.
    Hornum L, Hansen AJ, Tornehave D, Fjording MS, Colmenero P, Wätjen IF, Søe Nielsen NH, Bliddal H, Bartels EM.
    PLoS One; 2017 Jul 15; 12(12):e0189017. PubMed ID: 29220376
    [Abstract] [Full Text] [Related]

  • 38. Complement C5a/C5aR pathway potentiates the pathogenesis of gastric cancer by down-regulating p21 expression.
    Chen J, Li GQ, Zhang L, Tang M, Cao X, Xu GL, Wu YZ.
    Cancer Lett; 2018 Jan 01; 412():30-36. PubMed ID: 29031586
    [Abstract] [Full Text] [Related]

  • 39. IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway.
    Bai M, Zhang L, Fu B, Bai J, Zhang Y, Cai G, Bai X, Feng Z, Sun S, Chen X.
    Kidney Int; 2018 Apr 01; 93(4):814-825. PubMed ID: 29132705
    [Abstract] [Full Text] [Related]

  • 40. Inflammatory responses induced by lipopolysaccharide are amplified in primary human monocytes but suppressed in macrophages by complement protein C5a.
    Seow V, Lim J, Iyer A, Suen JY, Ariffin JK, Hohenhaus DM, Sweet MJ, Fairlie DP.
    J Immunol; 2013 Oct 15; 191(8):4308-16. PubMed ID: 24043889
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.